Video & Transcript DataContr Research : 'FDA'

Page 3 of 8
TX

Texas 2025 - 89th Regular

Public Health May 12th, 2025 at 08:05 am

House Public Health Committee

Transcript Highlights:
  • I'm an FDA regulatory consultant, so I have filed hundreds

  • Which is why vape products from China have to be FDA approved
  • , and there are no FDA-approved products coming out of China.
  • With some of those discussions, but they require FDA approval, and there are zero FDA-approved products
Summary: The meeting featured vigorous discussions around several significant bills, including SB2024 concerning youth vaping and its potential consequences. Witnesses presented compelling testimonies highlighting the dangers of e-cigarette use among teenagers, emphasizing how marketing tactics cleverly target this demographic. The bill faced no opposition during discussions but was left pending for further review and amendments. Additionally, HB5537 aimed to empower psychologists to prescribe medication, spurred different viewpoints from committee members about mental health measures and prescription regulations. Amidst these discussions, there was a focus on ensuring access to care while maintaining safety and quality standards.
TX

Texas 2025 - 89th Regular

State Affairs (Part II) Apr 28th, 2025

Senate State Affairs Committee

Transcript Highlights:
  • Chairman, the substitute preserves the intent of the original bill to ensure only lawful FDA-compliant
  • So anything that's not FDA-approved, even those that

  • Those that are approved by the FDA.
  • But I'm glad your bill has incorporated that in the statute that any FDA-approved
  • To clarify, it's the FDA-approved only that your bill is going to leave on the shelves?
Summary: The meeting saw significant discussions centered around several Senate bills, notably SB2487, SB1698, and SB2101. Senator Parker introduced and advocated for SB2487, which aims to enhance crisis service models for mental health interventions, receiving feedback from various stakeholders during formal testimony. The committee adopted the substitute version of this bill, which emphasizes local governance, expands service options, and tightens clinical timelines, responding to concerns from communities about service accessibility. Furthermore, the bill successfully passed from the committee with unanimous support, moving forward to the full Senate for consideration. In addition to SB2487, the committee reviewed SB1698, focusing on regulatory changes surrounding e-cigarette products. The committee recognized the importance of aligning state law with federal guidelines while ensuring strong consumer protections. Public testimonies included insights from enforcement officials and industry participants, highlighting the newly proposed measures aimed at preventing youth access to e-cigarettes. Lastly, SB2101, which addresses the regulation of sexually explicit materials in public libraries to ensure safe environments for minors, generated mix responses, with testimonies reflecting concerns over censorship and parental rights. The meeting concluded with the passage of SB2819 as well, which addresses political activities of county election administrators.
TX

Texas 2025 - 89th Regular

Public Health May 12th, 2025 at 10:05 am

House Public Health Committee

Transcript Highlights:
  • This is often required by the FDA to ensure reduced complications and improve patient outcomes.
  • We have an FDA mandate to teach them the safe and effective
  • I don't mean to be disrespectful, but your need for bodies to practice on is the FDA.
  • We have an FDA regulatory obligation to make sure that we
  • aspect that we've been talking about is for training and education once a device is approved by the FDA
Summary: The meeting of the Committee on Public Health was centered around discussions on several significant bills, including HB4175 and SB2721. HB4175 seeks to expand mental health leave policies to cover a wider range of qualified employees, including peace officers and parole officers. The motion for HB4175 was approved with a roll call vote showing a majority in favor. Conversely, SB2721 sparked extensive dialogue concerning the regulation of anatomical donations. Testimonies revealed public concerns over unclaimed bodies and the necessity for informed consent in body donation practices. The bill underwent substantial scrutiny, highlighting the balance between supporting medical education and protecting family rights.
TX

Texas 2025 - 89th Regular

89th Legislative Session May 7th, 2025 at 10:05 am

Texas House Floor Meeting

Transcript Highlights:
  • Mental health conditions have safe, affordable access to innovative treatment upon FDA approval.
  • ...substances that the FDA is in the process of rescheduling
Bills: HB200, HB541, HB1803, HB30, HB175, HB249, HB721, HB851, HB897, HB1128, HB1904, HB1916, HB5560, HB3071, HB5627, HB5435, HB3913, HB2921, HB2695, HB2688, HB3045, HB3483, HB3673, HB4213, HB4226, HB783, HB4373, HB4735, HB5155, HB5057, HB4984, HB4944, HB4813, HB5339, HB5196, HB5033, HB4853, HB3486, HB4211, HB74, HB4670, HB4730, HB4743, HB4603, HB4463, HB3892, HB4139, HB4752, HB4520, HB4517, HB4486, HB4437, HB4426, HB4396, HB4263, HB3487, HB3418, HB2284, HB2266, HB2229, HB4912, HB2189, HB4506, HB5269, HB5224, HB5195, HB3317, HB4166, HB3947, HB3358, HB3370, HB4438, HB3745, HB3602, HB3697, HB2001, HB1968, HB3371, HB3909, HCR7, SB1744, SB1364, SB1316, HB2026, HB3302, HB3368, HB1639, HB5652, HB4655, HB5654, HB5658, HB5656, HB4894, HB4996, HB5088, HB5650, HB4464, HB3751, HB5665, HB5661, HB1237, HB2802, HB5437, HB2703, HB5666, HB5667, HCR113, HCR86, SB2196, SB463, SB856, SB1245, SB1169, SB509, SB985, SB305, SB552, HB1535, HB123, HB1804, HB426, HB1773, HB1871, HB2035, HB2492, HB1411, HB4753, HB4666, HB4529, HB1499, HB1610, HB2028, HB1506, HB886, HB3546, HB796, HB223, HB3556, HB2448, HB4638, HB111, HB180, HB1027, HB1178, HB610, HB1277, HB1615, HB1620, HB5342, HB4885, HB4751, HB4530, HB4488, HB2149, HB2071, HB2282, HB2248, HB2243, HB2522, HB2310, HB2513, HB2300, HB1902, HB1813, HB3719, HB4284, HB3743, HB3778, HB5153, HB5147, HB4877, HB4850, HB3261, HB3005, HB3033, HB2849, HB2967, HB3531, HB1768, HB333, HB2914, HB2613, HB3717, HB3704, HB2697, HB3801, HB3099, HB3488, HB3477, HB3466, HB3396, HB3469, HB2594, HB2776, HB2564, HB2298, HB5331, HB5646, HB5247, HB5323, HB4384, HB3896, HB4014, HB3627, HB3594, HB2524, HB510, HB561, HB5111, HB5446, HB1181, HB3963, HB2785, HB1661, HB2460, HB200, HB541, HB1803, HB30, HB175, HB249, HB721, HB851, HB897, HB1128, HB1904, HB1916, HB5560, HB3071, HB5627, HB5435, HB3913, HB2921, HB2695, HB2688, HB3045, HB3483, HB3673, HB4213, HB4226, HB783, HB4373, HB4735, HB5155, HB5057, HB4984, HB4944, HB4813, HB5339, HB5196, HB5033, HB4853, HB3486, HB4211, HB74, HB4670, HB4730, HB4743, HB4603, HB4463, HB3892, HB4139, HB4752, HB4520, HB4517, HB4486, HB4437, HB4426, HB4396, HB4263, HB3487, HB3418, HB2284, HB2266, HB2229, HB4912, HB2189, HB4506, HB5269, HB5224, HB5195, HB3317, HB4166, HB3947, HB3358, HB3370, HB4438, HB3745, HB3602, HB3697, HB2001, HB1968, HB3371, HB3909, HCR98, HCR92, HCR126, HCR7
Summary: The committee meeting focused on the passage of multiple bills with significant discussions surrounding digital content authenticity, mental health treatments, and veterans' recognition. One of the notable moments was the passing of HB4437, which establishes requirements for the Department of Information Resources to authenticate digital media to combat misinformation through AI technologies. Representative Capriglione emphasized its importance in addressing the rise of synthetic media, which generated unanimous support among lawmakers. The meeting also included the passage of HB4014, concerning research on utilizing psychedelic therapies to treat mental health conditions. Lawmakers expressed enthusiasm about advancing innovative healthcare solutions in Texas.
TX
Transcript Highlights:
  • marker="256" data-time="1530"> More about these chemicals, and there's a whole discussion about the FDA
  • Actually, I think the FDA...

  • The FDA doesn't even study them.
  • The FDA director under President Biden said he doesn't even know all the chemicals in our food because
Summary: The meeting of the Senate Committee on Health and Human Services centered around two significant bills, SB25 and SB314, aimed at addressing the growing health crisis in Texas, particularly concerning children. The legislators acknowledged the prevalence of diet-related chronic health issues, including obesity and diabetes, and emphasized the need for a legislative response to improve dietary standards in schools. Senator Kocher championed SB25, which promotes measures like nutrition training for physicians, enhanced food labeling, and physical activity in schools as ways to combat the health crisis. Senator Hughes presented SB314, focusing specifically on prohibiting certain harmful chemicals in school meal programs and ensuring that children have access to healthier food options during school hours.
TX

Texas 2025 - 89th Regular

State Affairs Apr 7th, 2025 at 08:00 am

House State Affairs Committee

Transcript Highlights:
  • There's no FDA approval.
  • The FDA says that 10 mg of synthetic THC can trigger psychosis.
  • And so I stand by what the FDA supports, but I've seen the harm to my...
  • According to the FDA, just 10 milligrams of THC can trigger psychosis.
  • As regards to the FDA...
Bills: HB28, SB3
Summary: The meeting primarily focused on discussions surrounding HB28, which aims to regulate the hemp market in Texas following the 2018 Farm Bill. The committee heard testimonies from stakeholders including industry advocates and law enforcement representatives. Notably, there were opposing views on the efficacy and safety of the proposed regulations, particularly concerning the potential impact on children and the risks associated with unregulated THC products. Many witnesses emphasized the need for a balanced approach to ensure consumer safety while allowing responsible adult access to THC products.
TX

Texas 2025 - 89th 1st C.S.

State Affairs Jul 22nd, 2025

Senate State Affairs Committee

Transcript Highlights:
  • Those are currently legal today through the FDA.

  • Epidiolex is an FDA-approved CBD prescription. If a person under 21 needs CBD, they can.
  • And Federal law from day one said FDA approved whole hemp
  • They advise THC products as medicine despite lacking FDA approval.
  • It's not a well; that doesn't make it a medical directive because most of our drugs come from the FDA
Bills: SB5, SB11, SB12
Summary: The committee meeting focused on discussions surrounding public safety and health, particularly in relation to the regulation of THC products through Senate Bills 5, 11, and 12. A significant point of contention was Senate Bill 5, which sought to regulate THC products to prioritize child safety, with law enforcement officials arguing that existing regulations have failed to protect youth adequately. The committee heard several testimonies from both supporters and opponents of the legislation, emphasizing a deep divide on the efficacy of regulation versus prohibition. Lawmakers debated the implications of these bills, with some members advocating for a complete ban while others called for more moderate, regulated approaches to address the concerns surrounding THC consumption and its impact on mental health. Notably, the meeting concluded with a series of votes indicating a strong push towards tightening regulations on THC products to ensure public safety.
TX

Texas 2025 - 89th Regular

Finance Feb 6th, 2025

Senate Finance Committee

Transcript Highlights:
  • that's required to deal with the FDA.
  • FDA.
  • We have a dedicated FDA team.
  • FDA approval leads to payment coming back to MD Anderson.
  • You know, I think the FDA...
Bills: SB1
Summary: The meeting of the committee was primarily focused on budget requests and legislative priorities from various educational institutions. Each institution expressed the need for increased funding to support academic programs, STEM education, and critical health initiatives. For instance, representatives from UT Dallas highlighted the importance of their Fentanyl Protection Initiative and advances in pain therapy, reaffirming their commitment to combat the opioid crisis in Texas. Other notable discussions included the need for updates to campus infrastructure and the request for new programs aimed at enhancing workforce development across various fields, particularly healthcare and technology. Topics such as the restoration of Institutional Enhancement Funds and the increase of appropriations for research initiatives were also extensively discussed. The meeting concluded with a call for collaboration among universities to strengthen Texas's overall higher education landscape.
TX

Texas 2025 - 89th 2nd C.S.

State Affairs Aug 22nd, 2025 at 08:08 am

House State Affairs Committee

Transcript Highlights:
  • There was a recent note from the FDA; this is the FDA. They reviewed the data.
  • But if you do have doubts about that study, the FDA claims its serious adverse effects...
  • And this FDA number is also from before the pills were available in the form and the like.
  • Bills aren't even FDA-regulated, being shipped from out of the country with little to no direction.
  • That same study revealed that these pills are 22 times more dangerous than what the FDA has...
Bills: HB7, SB8
Summary: Simultaneously, SB8 initiated thorough debates over privacy and safety concerns in public restrooms. Supporters argued for the necessity of maintaining biologically separated spaces to protect women and children, while opponents highlighted the discrimination and potential harm caused to transgender individuals. Various stakeholders, including business representatives and community activists, voiced their opposition to SB8, emphasizing its negative implications for Texas's reputation as a welcoming state. The session concluded without any definitive resolutions, with both bills remaining pending for further consideration.
TX

Texas 2025 - 89th Regular

Health and Human Services Mar 18th, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • The original Right to Try gave patients the right to seek treatments that had passed the FDA safety trials
  • The FDA develops and approves more drugs than any other country in the world.
  • However, when previously approved treatments do not work for suffering patients, the FDA is simply too
  • The FDA, by its nature, amasses significant data.
  • It's unrealistic to expect the FDA to move as quickly as
Summary: The meeting of the committee was focused predominantly on various bills concerning healthcare and insurance policies, reflecting significant discussions on how these laws impact the community. Notably, Senate Bill 660 was introduced to enhance safety measures at healthcare facilities, discussing the necessity for bollards to prevent unauthorized vehicular access, highlighting a bipartisan understanding of public safety. Senator West emphasized the importance of these regulations, citing real-world incidents that necessitate such actions. Public testimonies complimented this discussion, providing insight into community needs for enhanced security in hospitals.
TX

Texas 2025 - 89th Regular

Senate Session May 16th, 2025

Texas Senate Floor Meeting

Bills: SB128, SB203, SB317, SB393, SB397, SB731, SB781, SB801, SB867, SB1071, SB1086, SB1087, SB1232, SB1262, SB1444, SB1483, SB1782, SB1798, SB1861, SB1897, SB1944, SB2023, SB2082, SB2215, SB2309, SB2497, SB2549, SB2566, SB2603, SB2607, SB2617, SB2688, SB2797, SB2799, SB2841, SB2891, SB2919, SB2928, SB2969, SB2994, SB3070, HB11, HB12, HB26, HB33, HB34, HB45, HB48, HB130, HB148, HB198, HB210, HB303, HB647, HB668, HB677, HB762, HB791, HB1022, HB1041, HB1188, HB1240, HB1242, HB1261, HB1318, HB1397, HB1465, HB1520, HB1535, HB1729, HB1778, HB1950, HB2003, HB2027, HB2029, HB2559, HB2596, HB2607, HB2692, HB2712, HB2742, HB2768, HB2775, HB2788, HB2802, HB2894, HB3474, HB3594, HB3611, HB3698, HB3699, HB3700, HB4187, HB4753, HB4804, HB4850, HB4885, HB5061, HB5238, HB5560, HCR90, SJR34, SB529, SB541, SB693, SB963, SB1173, SB1646, SB1734, SB1833, SB1968, SB2544, SB1, SB17, SB260, SB509, SB1506, SB1637, SB2308, SJR36, SJR50, SJR63, SCR12, SCR39, SB2023, SB128, SB2309, SB1861, SB2617, SB62, SB666, SB847, SB284, SB854, SB810, SB1505, SB583, SB507, SB1434, SB1772, SB2016, SB1122, SB731, SB397, SB508, SB1436, SB287, SB1882, SB393, SB1791, SB209, SB2429, SB511, SB1085, SB1975, SB2717, SB1262, SB636, SB2056, SB884, SB1200, SB1845, SB2458, SB801, SB3014, SB3013, SB758, SB2797, SB2076, SB2876, SB1640, SB1449, SB1181, SB1234, SB2926, SB2841, SB1528, SB2891, SB1854, SB317, SB1250, SB2082, SB1237, SB2819, SB629, SB2608, SB1602, SB2009, SB867, SB640, SB1698, SB2680, SB913, SB1071, SB1086, SB1087, SB1483, SB1444, SB1553, SB1556, SB1703, SB2133, SB2297, SB2298, SB2622, SB2955, SB2334, SB1367, SB2044, SB2363, SB2565, SB1888, SB3036, SB3057, SB3043, SB3063, SB3035, SB203, SB2799, SB2688, SB2522, SB2459, SB2655, SB2251, SB1884, SB2928, SB2566, SB1749, SB2549, SB2553, SB2919, SB1782, SB1944, SB1232, SB2969, SB2497, SB1798, SB2603, SB2607, SB781, SB524, SB2233, SB2683, HB1393, HB2559, HB26, HB2607, HB3810, HB388, HB12, HB2712, HB2692, HB1633, HB1318, HB685, HB4753, HB2742, HB303, HB198, HB1535, HB762, HB148, HB1520, HB5061, HB2286, HB1606, HB1041, HB132, HB11, HB45, HB48, HB1261, HB1465, HB1778, HB2596, HB5238, HB33, HB1188, HB210, HB1022, HB1458, HB5560, HB1240, HB1950, HB2027, HB2768, HB2788, HB2791, HB3146, HB3698, HB3699, HB1893, HB3700, HB4850, HB4187, HB1397, HB4885, HB4804, HB3751, HB3611, HB2775, HB2061, HB2003, HB1729, HB1242, HB791, HB2029, HB647, HB2522, HB4738, HB3033, HB3594, HB3474, HB2563, HB2802, HB34, HB128, HB130, HB581, HB668, HB677, HB766, HB2259, HB2960, HB2358, HB2894, HB4384, HB2663, HB748, HB793, HB1193, HB1734, HB2340, HB2350, HB3104, HB5180, HB4739, HB1584, HB4344, HB4238, HB4219, HB3806, HB3805, HB3804, HB3803, HB3229, HB3228, HB1922, HB1522, HB431, HB3597, HB1612, HB4224, HB754, HB1314, HB2254, HB2789, HB3560, HB4643, HB1237, HCR90, HCR98, SJR60, SB1319, SB1978, SB3038, SB3045, SB1633, HB3126, HB2856, HB3114, HB3041, HB3505, HB4205, HB5652, HB3687, HB5424, HB4506, HB3370, HB2025, HB4273
Summary: The meeting involved extensive discussions on several key legislative bills, notably HB1188 and HB1535, both aimed at enhancing support systems for vulnerable populations. HB1188, known as the Caitlin Handley Act, mandates school districts to provide information about local intellectual and developmental disability services to parents of special education students. It passed without objections and was recognized for its potential to improve awareness and access to critical resources. Similarly, HB1535 focused on governance improvements for the Trinity River Authority, emphasizing transparency and accountability in its operations. The bill received strong support and moved forward smoothly through the legislative process.
TX

Texas 2025 - 89th Regular

Health and Human Services Apr 2nd, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • The FDA has approved five therapies for Duchenne, including

  • reach due to technological advances that have recently been made, including the availability of an FDA-approved
  • " data-time="5328"> progress through the successful completion of multiple pilot programs utilizing FDA-authorized
Summary: The Senate Committee on Health and Human Services convened to discuss several significant bills, including SB968, SB966, and SB437. Senator Zaffirini presented SB968, which aims to modernize podiatry regulations in alignment with current practices, while SB966 involves the licensing and regulation of podiatry, addressing outdated provisions following a 2017 transition to the Texas Department of Licensing and Regulation. Both bills indicate a necessary clean-up of statutory language to better reflect contemporary standards in healthcare regulations. Additionally, Senator Hinojosa proposed SB437, which focuses on providing effective regulatory frameworks for chemical dependency treatment facilities, highlighting an urgent increase in demand due to rising substance abuse rates post-COVID-19.
TX

Texas 2025 - 89th Regular

Public Health May 19th, 2025 at 10:05 am

House Public Health Committee

Transcript Highlights:
  • Therapeutic is defined by FDA approved indications.
  • These indications are FDA approved, and there are clinical
Summary: During this meeting of the Committee on Public Health, members discussed several significant bills focused on expanding the scope of practice for dental professionals, specifically regarding the administration of neuromodulators such as Botox for aesthetic purposes. Senator Van Dever presented SB1117, which would allow licensed dentists to administer these treatments following proper training, a point that sparked a lively debate among committee members. While proponents emphasized the benefits of improving patient access to regulated aesthetic care, opponents raised concerns about the potential for dentists to prioritize cosmetic procedures over essential dental care, fearing that the marketplace could prioritize profit over patient safety. The bill enjoyed bipartisan support, having passed the Senate unanimously but faced scrutiny regarding the implications of allowing such expansion beyond traditional dental practices.
TX

Texas 2025 - 89th 1st C.S.

Public Health Aug 13th, 2025 at 09:08 am

House Public Health Committee

Transcript Highlights:
  • And it mimics Senate Bill 5, which protects FDA-approved
  • So we tried to think, okay, if it's FDA-approved THC, that means it's gone through a medical review.
  • It's FDA dietary... ...supplement regulations.
  • amount that the FDA would even say induces psychosis.
  • We have agencies like the FDA, TABC, and DSHS.
Bills: HB5
Summary: The meeting of the Public Health Committee focused primarily on discussions surrounding HB5, which seeks to regulate THC consumables in Texas. Numerous witnesses provided testimony, both in favor and against the bill, highlighting concerns regarding public health and safety as well as the economic implications of regulation versus prohibition. Chairman Van Dever and other committee members actively engaged with witnesses to clarify the potential impact of the proposed legislation. The testimonies brought to light intense disagreements over how best to approach the management of hemp and cannabis products, demonstrating a division between those advocating for strict regulations versus those calling for responsible oversight without outright bans on THC.
TX
Transcript Highlights:
  • The FDA requires an in-person VCPR, as well as the USDA for various reasons.
  • That's why the FDA makes it absolutely crucial that you have a Veterinary-Client-Patient Relationship
  • by the FDA, but it is also evaluated for livestock animals
  • Three companies have received FDA approval.
  • And in 2019, President Trump's USDA and FDA developed a formal agreement...
Summary: The meeting was convened to discuss various Senate Bills, focusing on issues pertinent to agriculture, environment, and public health. Notably, Senator Perry spearheaded discussions on SB1247 and SB1948, emphasizing the need for committee substitutes to adapt the bills to recent legislative requirements. SB1948, in particular, was introduced to exempt agricultural structures from certain fire safety regulations, reflecting concerns among agricultural producers regarding compliance costs. Multiple members supported this legislation, highlighting the impact on the agricultural sector's operational viability.
TX

Texas 2025 - 89th Regular

Human Services Apr 22nd, 2025 at 08:04 am

House Human Services Committee

Transcript Highlights:
  • ...to the only FDA-approved medication.
  • These are highly regulated by the FDA; we can't.
  • This is an FDA Category 3 device, so it's highly regulated, the materials that are used, the equipment
  • They are Class 2 FDA medical equipment.
Summary: The meeting of the committee focused on several key bills related to health care and adoption services, with a significant emphasis on fostering care systems. Vice Chair Emanuel presented bills that aimed to streamline reporting requirements for the HHSC, while Representative Slauson's bill on voluntary adoption registries prompted a discussion on improving access and procedures within the child welfare system. Each bill was generally met with favorable votes, indicating strong bipartisan support for these initiatives. The committee heard testimonies from various stakeholders who voiced the importance of these legislative efforts in enhancing the quality of life for children and families involved in the welfare system. Notably, the committee also tackled the issue of Medicaid services and accessibility for children needing medical equipment like baby helmets, which have been a burden for many low-income families.
TX

Texas 2025 - 89th Regular

89th Legislative Session May 25th, 2025 at 02:05 pm

Texas House Floor Meeting

Transcript Highlights:
  • Well, I mean, it could be FDA, it could be USDA,

  • span marker="3049" data-time="18288"> have healthy food and so you know it could be something from the FDA
  • I would assume that if it comes out of the FDA that the
  • Are you aware that the FDA has oversight over certain

  • What does the FDA do?
Bills: SB835, SB3070, SB22, SJR59, SB926, SB1494, SB251, SB456, SB500, SB1307, SB2615, SB2995, SB2321, SB973, SB974, SB865, SB506, SB781, SB1522, SB1558, SB510, SB667, SB763, SB2073, SB1858, SB1660, SB505, SB2900, SB1433, SB1540, SB1964, SB1300, SB1644, SB2217, SB2373, SB2431, SB1758, SB2480, SB3039, SB3047, SB3073, SB2920, SB2781, SB826, SB766, SB2460, SB527, SB1946, SB2885, SB1243, SB2610, SB2595, SB857, SB37, SB8, SB10, SB227, SB261, SB12, SB15, SJR27, SB552, SB835, SB3070, SB22, SJR59, SB25, SB57, SB127, SB293, SB441, SB3059, SB512, SB241, SB1718, SB140, SB2055, SB2075, SB2018, SB1534, SB1567, SB785, SB1233, SB1580, SB1663, SB413, SB447, SB519, SB467, SB1579, SB1191, SB1021, SB1838, SB2807, SB2835, SB546, SB2121, SB2167, SB2035, SB2024, SB1032, SB1049, SB1266, SB1400, SB1302, SB401, SB1596, SB1281, SB1242, SB1343, SB310, SB1346, SB2753, SB2703, SB2221, SB1719, SB2177, SB800, SB790, SB748, SB571, SB1957, SB1923, SB1896, SB1760, SB1335, SB2368, SB2477, SB2587, SB2972, SB2986, SB2965, SB1563, SB1467, SB1164, SB1137, SB614, SB705, SB961, SB918, SB955, SB869, SB850, SB863, SB1610, SB1055, SB2206, SB457, SB2337, SB1362, SB926, SB1494, SB251, SB456, SB500, SB1307, SB2615, SB2995, SB2321, SB973, SB974, SB865, SB506, SB781, SB1522, SB1558, SB510, SB667, SB763, SB2073, SB1858, SB1660, SB505, SB2900, SB1433, SB1540, SB1964, SB1300, SB1644, SB2217, SB2373, SB2431, SB1758, SB2480, SB3039, SB3047, SB3073, SB2920, SB2781, SB826, SB766, SB2460, SB527, SB1946, SB2885, SB1243, SB2610, SB2595, SB857, SCR9, HB5560, HB762, HB107, HB114, HB300, HB138, HB4386, HB2495, HB581, HB3348, HB5323
Summary: The meeting covered a variety of bills including discussions around SB261, SB12, and SB15, with members expressing diverse viewpoints on their implications. A significant focus was on SB12, also known as the Texas Parent Bill of Rights, which sparked a debate over parental rights in public education and the responsibilities of school districts. The bill passed with a notable vote of 88 to 47, reflecting its contentious nature. Other bills like SB15 were challenged, raising concerns about their potential to limit application to specific municipalities and address the ongoing affordability crisis in Texas by modifying residential housing requirements. Overall, the atmosphere was characterized by vibrant debate and active participation from both members and the public.
TX

Texas 2025 - 89th 2nd C.S.

Health and Human ServicesAudio only. Aug 27th, 2025

Senate Health & Human Services Committee

Transcript Highlights:
  • I won't dispute that Ivermectin is FDA approved for certain

Bills: HB25
Summary: The meeting of the Senate Committee on Health and Human Services predominantly focused on discussions surrounding House Bill 25, which proposes allowing pharmacists to dispense ivermectin over the counter. Senator Hall, the bill's sponsor, outlined the potential benefits of increased access to ivermectin, particularly for rural Texans who may struggle to get timely medical care. The discussions included various perspectives on the safety and efficacy of ivermectin as a treatment for viral infections, with witnesses providing testimonials on its use. Senator Hall emphasized that the bill would promote medical freedom by enabling pharmacists to dispense the drug without a prescription, yet concerns were raised regarding the off-label use of such drugs and the responsibilities of pharmacists under this bill.
TX

Texas 2025 - 89th Regular

Senate Session Mar 13th, 2025

Texas Senate Floor Meeting

Bills: SJR18, SCR9, SCR13, SB10, SB14, SB19, SB263, SB412, SB441, SB523, SB569, SB687, SB688, SB707, SB766, SB914, SB971, SB1006, SB1066, SJR36, SJR18, SCR9, SCR13, SCR25, SB565, SB372, SB495, SB842, SB971, SB1066, SB765, SB523, SB62, SB19, SB18, SB666, SB688, SB707, SB888, SB687, SB706, SB847, SB290, SB766, SB11, SB10, SB13, SB263, SB412, SB441, SB569, SB914, SB1248, SB740, SB14, SB1006, SB504, SB917, SB925, SB388, SB1902, SB1121, SB995, SB857, SB305, SB296, SB284, SB35, SB6, SB815, SB3, SB1281, SB1379, SB1300, SB1497, SB1499, SB1498, SB1451, SB263, SB523, SB569, SB688, SB766, SB914, SB971, SB1066, SR215, SR245, SR247, SR258, SCR9, SJR56, SJR63, SJR64, SJR69, SJR70, SJR71, SCR30, SCR31, SCR32, SCR33, SB1701, SB1702, SB1703, SB1704, SB1705, SB1706, SB1707, SB1708, SB1709, SB1710, SB1711, SB1712, SB1713, SB1714, SB1715, SB1716, SB1717, SB1718, SB1719, SB1720, SB1721, SB1722, SB1723, SB1724, SB1725, SB1726, SB1727, SB1728, SB1729, SB1730, SB1731, SB1732, SB1733, SB1734, SB1735, SB1736, SB1737, SB1738, SB1739, SB1740, SB1741, SB1742, SB1743, SB1744, SB1745, SB1746, SB1747, SB1748, SB1749, SB1750, SB1751, SB1752, SB1753, SB1754, SB1755, SB1756, SB1757, SB1758, SB1759, SB1760, SB1761, SB1762, SB1763, SB1764, SB1765, SB1766, SB1767, SB1768, SB1769, SB1770, SB1771, SB1772, SB1773, SB1774, SB1775, SB1776, SB1777, SB1778, SB1779, SB1781, SB1782, SB1783, SB1784, SB1785, SB1786, SB1787, SB1788, SB1789, SB1790, SB1791, SB1792, SB1793, SB1794, SB1795, SB1796, SB1797, SB1798, SB1799, SB1800, SB1801, SB1802, SB1803, SB1804, SB1805, SB1806, SB1807, SB1808, SB1809, SB1810, SB1811, SB1812, SB1813, SB1814, SB1815, SB1816, SB1817, SB1818, SB1819, SB1820, SB1821, SB1822, SB1823, SB1824, SB1825, SB1826, SB1827, SB1828, SB1829, SB1830, SB1831, SB1832, SB1833, SB1834, SB1835, SB1836, SB1837, SB1838, SB1839, SB1840, SB1841, SB1842, SB1843, SB1844, SB1845, SB1846, SB1847, SB1848, SB1849, SB1850, SB2188, SB2230, SB2312, SB2345, SJR56, SJR63, SJR64, SJR69, SJR70, SJR71, SCR30, SCR31, SCR32, SCR33, SB1701, SB1702, SB1703, SB1704, SB1705, SB1706, SB1707, SB1708, SB1709, SB1710, SB1711, SB1712, SB1713, SB1714, SB1715, SB1716, SB1717, SB1718, SB1719, SB1720, SB1721, SB1722, SB1723, SB1724, SB1725, SB1726, SB1727, SB1728, SB1729, SB1730, SB1731, SB1732, SB1733, SB1734, SB1735, SB1736, SB1737, SB1738, SB1739, SB1740, SB1741, SB1742, SB1743, SB1744, SB1745, SB1746, SB1747, SB1748, SB1749, SB1750, SB1751, SB1752, SB1753, SB1754, SB1755, SB1756, SB1757, SB1758, SB1759, SB1760, SB1761, SB1762, SB1763, SB1764, SB1765, SB1766, SB1767, SB1768, SB1769, SB1770, SB1771, SB1772, SB1773, SB1774, SB1775, SB1776, SB1777, SB1778, SB1779, SB1781, SB1782, SB1783, SB1784, SB1785, SB1786, SB1787, SB1788, SB1789, SB1790, SB1791, SB1792, SB1793, SB1794, SB1795, SB1796, SB1797, SB1798, SB1799, SB1800, SB1801, SB1802, SB1803, SB1804, SB1805, SB1806, SB1807, SB1808, SB1809, SB1810, SB1811, SB1812, SB1813, SB1814, SB1815, SB1816, SB1817, SB1818, SB1819, SB1820, SB1821, SB1822, SB1823, SB1824, SB1825, SB1826, SB1827, SB1828, SB1829, SB1830, SB1831, SB1832, SB1833, SB1834, SB1835, SB1836, SB1837, SB1838, SB1839, SB1840, SB1841, SB1842, SB1843, SB1844, SB1845, SB1846, SB1847, SB1848, SB1849, SB1850, SB2188, SB2230, SB2312, SB2345
Summary: The committee meeting involved deep discussions surrounding several bills, particularly SB4 and HB2214. A significant portion of the meeting was dedicated to public testimonies, where multiple stakeholders voiced their opinions and concerns regarding the implications of these bills on local communities. Members of the committee actively engaged with the witnesses, asking questions to clarify the potential impacts of the proposed legislation. There seemed to be a variety of sentiments expressed among the speakers, ranging from strong support to substantial concern about the bills' consequences.
TX

Texas 2025 - 89th Regular

Public Health Apr 14th, 2025 at 02:04 pm

House Public Health Committee

Transcript Highlights:
  • In FDA terminology, a label refers to the written, printed
  • and medications we produce are already highly regulated by the Texas State Board of Pharmacy and the FDA
  • Compounded medications are personalized medications made by pharmacists using FDA-approved ingredients
  • ...example to show you how we use different FDA-approved
  • have to follow more rigorous guidelines that are put forward by state accrediting agencies and the FDA
Summary: The meeting convened to discuss various health-related bills, with significant emphasis placed on addressing substance abuse and the associated healthcare challenges in Texas. Notable discussions revolved around HB5342, which aims to sustain 988 operations to aid individuals in crisis, while HB4454 focuses on updating laws to combat unethical patient brokering within substance use treatment programs. Various witnesses, including healthcare professionals, provided testimony supporting these initiatives, highlighting the impact of substance abuse on public health and the necessity for legislative backing in these areas. The committee heard from several members who articulated the urgency of implementing effective measures to address substance abuse, especially with the rising concerns around opioid-related deaths and treatment accessibility in underserved areas.

Research Filters

States
Terms / Sessions
Date Range
Chamber Records
Meetings / Events / Calendars